Pfizer Inc. exceeded Wall Street expectations in its first-quarter report, posting adjusted earnings per share of $0.75, surpassing predictions by four cents. The company also recorded a revenue increase of 5%, totaling $14.45 billion compared to the previous year. Looking ahead, Pfizer remains optimistic, reaffirming its 2026 sales guidance of $59.5 billion to $62.5 billion, as anticipation builds for its upcoming third-quarter earnings release on May 5.
“Pfizer Inc. · will release earnings for · third quarter · before the opening bell on Tuesday, May 5”
“Pfizer Inc. · expected quarterly earnings · per share · 72 cents”
“Pfizer Inc. · reported quarterly earnings · per share · 92 cents”
“Pfizer Inc. · reported last year's revenue · quarterly revenue · $13.71 billion”
“Pfizer PFE · earnings per share · Q1 · +0.75”
“Pfizer PFE · earnings expectations beat · Q1 · +4 cents”
“Pfizer PFE · revenue · Q1 · $14.45 billion”
“Pfizer PFE · revenue growth · Q1 · +4.56%”
“Pfizer Inc. · will release earnings for · third quarter · before the opening bell on Tuesday, May 5”
“Pfizer Inc. (NYSE:PFE) · was · among the stocks on Jim Cramer’s radar · true”
“Pfizer Inc. (NYSE:PFE) · develops and sells · medicines and vaccines for several health conditions · true”
“Pfizer Inc. · is about to go ex-dividend in · three days · true”
.svg&width=160)